Botox News and Research

RSS

Botox is a drug made from a toxin produced by the bacterium Clostridium botulinum. It's the same toxin that causes a life-threatening type of food poisoning called botulism. Doctors use it in small doses to treat health problems, including, temporary removal of facial wrinkles, severe underarm sweating, cervical dystonia - a neurological disorder that causes severe neck and shoulder muscle contractions, blepharospasm - uncontrollable blinking, strabismus - misaligned eyes. Botox injections work by weakening or paralyzing certain muscles or by blocking certain nerves. The effects last about three to four months. Side effects can include pain at the injection site, flu-like symptoms, headache and upset stomach. Injections in the face may also cause temporary drooping eyelids. You should not use Botox if you are pregnant or breast feeding.

FDA approves use of Botox Cosmetic to treat crow's feet

The FDA approved the use of Botox Cosmetic to treat crow's feet on September 11th, 2013 after a trial of 833 adults showed the treatments reduced the appearance of wrinkles.

29 Oct 2013

Using Botox as weight loss tool in rats

Researchers from the Norwegian University of Science and Technology have had promising experimental results from using Botox as a weight loss tool in rats. The research group hopes to win approval for human testing in the near future.

5 Oct 2013

Allergan Licenses Rights To Medytox Candidates, In Up-To-$362M Deal

...

26 Sep 2013

Botox Cosmetic receives FDA approval for treatment of crow’s feet lines

The U.S. Food and Drug Administration today approved a new use for Botox Cosmetic (onabotulinumtoxinA) for the temporary improvement in the appearance of moderate to severe lateral canthal lines, known as crow’s feet, in adults. Botox Cosmetic is the only FDA approved drug treatment option for lateral canthal lines.

12 Sep 2013

Botox also treats facial nerve disorders that occur after Bell's palsy

Botox is best known as a cosmetic treatment for frown lines, but the drug also effectively treats the after effects of Bell's palsy and other serious facial nerve problems.

28 Aug 2013

Aquavit Pharmaceuticals signs licensing agreement with U-Bio Med for microneedle technology

Aquavit Pharmaceuticals, Inc. announces it has signed a definitive licensing agreement with U-Bio Med Inc., a medical technology device company in South Korea, for the worldwide commercialization of the company's microneedle device technology.

19 Jul 2013

State highlights: Conn. bill would maintain coverage for low-income parents; Wis. may pay hospitals for uninsured care; Is hospital data sale a risk to patient privacy?

The House of Representatives adopted an omnibus bill Tuesday to implement numerous social service policy changes in the next state budget, including the end of a health coverage program launched by former Gov. M. Jodi Rell to help the uninsured. One thing it doesn't change: Medicaid eligibility for low-income parents. Gov. Dannel P. Malloy had proposed restricting eligibility for the program, a move that would have caused an estimated 37,500 parents to lose Medicaid coverage (Phaneuf and Becker, 6/4).

6 Jun 2013

First Edition: June 5, 2013

Today's headlines include reports about the questions about fundraising phone calls faced by HHS Secretary Kathleen Sebelius during a Capitol Hill hearing.

5 Jun 2013

Majority of children with spastic cerebral palsy experience long-term benefits of SDR

Selective dorsal rhizotomy is a surgical procedure used to treat spasticity in some children with spastic cerebral palsy. This procedure appears to be effective, but for how long? Researchers from Montreal, Quebec, Canada, set out to find the answer to this question by studying data from the McGill University Rhizotomy Database on 102 pediatric patients with long-term follow-up.

29 May 2013

Peripheral neuropathic pain patch treatments: an interview with Anne Hodgkins, Astellas Pharma

Peripheral neuropathic pain is caused by lesion or disease to the peripheral somatosensory nervous system. Nerve damage that can lead to peripheral neuropathic pain can happen as a result of a range of different diseases, medications or traumatic injuries.

8 May 2013

Study results support new view of molecules important for nerve cell signaling

National Institutes of Health researchers used the popular anti-wrinkle agent Botox to discover a new and important role for a group of molecules that nerve cells use to quickly send messages.

3 May 2013

Athletes with vocal cord disorder inappropriately treated for exercise-induced asthma

Athletes with a vocal cord disorder that restricts breathing are more likely to be misdiagnosed and inappropriately treated for exercise-induced asthma, according to research presented today at the Triological Society's 116th Annual Meeting.

15 Apr 2013

Facial plastic surgeon adds Pelleve Wrinkle Reduction System into Main Line Center for Laser Surgery

Facial plastic and reconstructive surgeon Dr. Jason D. Bloom knows anti-aging. That's why he's just introduced the Pelleve Wrinkle Reduction System into the Main Line Center for Laser Surgery where he's committed to helping patients look their best.

8 Apr 2013

Study now tells physicians that dystonia can occur in African-American patients

A pair of studies tells the tale of how a neuroscientist at Mayo Clinic in Florida helped to discover the first African-American family to have inherited the rare movement disorder dystonia, which causes repetitive muscle contractions and twisting, resulting in abnormal posture.

7 Mar 2013

UK cosmetic procedures standards announced

The Royal College of Surgeons has published a report on the professional standards, competencies and behaviors expected for physicians, nurses, and dentists performing cosmetic procedures in the UK.

5 Feb 2013

Botulinum toxin A does not promote weight loss in obese patients

Despite conflicting data in support of the practice, some overweight Americans looking for an easy fix have turned to gastric botox injections to help them lose weight. This month in Clinical Gastroenterology and Hepatology, the official clinical practice journal of the American Gastroenterological Association, researchers from the Mayo Clinic publish a definitive study finding that Botox doesn't promote weight loss.

29 Jan 2013

Botox relieves plantar fasciitis pain

Botulinum toxin A may be more effective than steroids for the treatment of plantar fasciitis, research suggests.

25 Jan 2013

FDA approves Allergan’s BOTOX to treat overactive bladder

Allergan, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved BOTOX (onabotulinumtoxinA) for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency and frequency in adults who have had an inadequate response to or are intolerant of an anticholinergic medication.

19 Jan 2013

Allergan receives FDA approval for Botox to treat overactive bladder

The U.S. Food and Drug Administration today expanded the approved use of Botox (onabotulinumtoxinA) to treat adults with overactive bladder who cannot use or do not adequately respond to a class of medications known as anticholinergics.

18 Jan 2013

Botulinum toxin A more effective than intralesional steroids in treating plantar fasciitis

Plantar fasciitis is the most frequent cause of chronic heel pain, leaving many sufferers unable to put their best foot forward for months at a time. Now a Mexican study suggests that physicians should turn to Botox rather than steroids to offer patients the fastest road to recovery.

18 Jan 2013